Surmodics ROA 2010-2025 | SRDX
Current and historical return on assets (ROA) values for Surmodics (SRDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Surmodics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.02B | $0.16B | -11.71% |
| 2024-12-31 | $-0.02B | $0.16B | -8.53% |
| 2024-09-30 | $-0.01B | $0.18B | -6.68% |
| 2024-06-30 | $0.00B | $0.18B | -1.10% |
| 2024-03-31 | $0.01B | $0.18B | 7.05% |
| 2023-12-31 | $0.01B | $0.18B | 2.77% |
| 2023-09-30 | $0.00B | $0.19B | -1.13% |
| 2023-06-30 | $-0.02B | $0.19B | -14.06% |
| 2023-03-31 | $-0.04B | $0.17B | -22.09% |
| 2022-12-31 | $-0.03B | $0.17B | -19.19% |
| 2022-09-30 | $-0.03B | $0.16B | -15.93% |
| 2022-06-30 | $-0.01B | $0.18B | -7.03% |
| 2022-03-31 | $-0.01B | $0.18B | -5.40% |
| 2021-12-31 | $0.00B | $0.19B | 1.09% |
| 2021-09-30 | $0.01B | $0.20B | 2.81% |
| 2021-06-30 | $0.00B | $0.18B | 1.16% |
| 2021-03-31 | $0.01B | $0.18B | 4.14% |
| 2020-12-31 | $0.00B | $0.16B | 0.00% |
| 2020-09-30 | $0.00B | $0.17B | 0.00% |
| 2020-06-30 | $0.01B | $0.17B | 4.40% |
| 2020-03-31 | $0.01B | $0.16B | 3.86% |
| 2019-12-31 | $0.01B | $0.16B | 3.90% |
| 2019-09-30 | $0.01B | $0.16B | 4.58% |
| 2019-06-30 | $0.00B | $0.15B | 0.65% |
| 2019-03-31 | $0.00B | $0.15B | -1.92% |
| 2018-12-31 | $0.00B | $0.15B | -1.25% |
| 2018-09-30 | $-0.01B | $0.16B | -3.22% |
| 2018-06-30 | $0.00B | $0.16B | -2.02% |
| 2018-03-31 | $0.00B | $0.16B | 0.71% |
| 2017-12-31 | $0.00B | $0.14B | 0.00% |
| 2017-09-30 | $0.00B | $0.14B | 3.02% |
| 2017-06-30 | $0.01B | $0.13B | 5.33% |
| 2017-03-31 | $0.01B | $0.13B | 7.69% |
| 2016-12-31 | $0.01B | $0.13B | 7.83% |
| 2016-09-30 | $0.01B | $0.13B | 8.91% |
| 2016-06-30 | $0.01B | $0.13B | 7.83% |
| 2016-03-31 | $0.01B | $0.12B | 8.39% |
| 2015-12-31 | $0.01B | $0.11B | 11.06% |
| 2015-09-30 | $0.01B | $0.10B | 12.87% |
| 2015-06-30 | $0.01B | $0.10B | 13.72% |
| 2015-03-31 | $0.01B | $0.09B | 13.54% |
| 2014-12-31 | $0.01B | $0.09B | 12.34% |
| 2014-09-30 | $0.01B | $0.11B | 12.09% |
| 2014-06-30 | $0.01B | $0.10B | 14.21% |
| 2014-03-31 | $0.01B | $0.10B | 13.10% |
| 2013-12-31 | $0.02B | $0.10B | 14.67% |
| 2013-09-30 | $0.02B | $0.10B | 14.22% |
| 2013-06-30 | $0.01B | $0.10B | 13.21% |
| 2013-03-31 | $0.01B | $0.11B | 11.72% |
| 2012-12-31 | $0.01B | $0.11B | 9.16% |
| 2012-09-30 | $0.01B | $0.10B | 7.75% |
| 2012-06-30 | $-0.01B | $0.16B | -7.09% |
| 2012-03-31 | $-0.01B | $0.15B | -6.29% |
| 2011-12-31 | $-0.01B | $0.15B | -6.12% |
| 2011-09-30 | $-0.02B | $0.16B | -11.28% |
| 2011-06-30 | $-0.02B | $0.17B | -12.81% |
| 2011-03-31 | $-0.03B | $0.17B | -15.32% |
| 2010-12-31 | $-0.03B | $0.17B | -16.02% |
| 2010-09-30 | $-0.02B | $0.17B | -11.31% |
| 2010-06-30 | $0.00B | $0.19B | 2.11% |
| 2010-03-31 | $0.01B | $0.19B | 4.80% |
| 2009-12-31 | $0.01B | $0.19B | 7.02% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.410B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |